Phillip Pang, Chief Medical Officer at Vir Biotechnology, Inc. (VIR), sold 8,995 shares at $50.43 ($446K) on 2021-09-01, disclosed to the SEC on 2021-09-02.
Open-market sale of $446k VIR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.72 | 1,888 | $92K | 20.6% |
| 2 | $48.72 | 1,888 | $92K | 20.6% |
| 3 | $49.40 | 1,005 | $50K | 11.1% |
| 4 | $50.43 | 2,107 | $106K | 23.8% |
| 5 | $50.43 | 2,107 | $106K | 23.8% |
| Total | $49.60 avg | 8,995 |
| $446K |
| 100% |
| Filing → |
| VIR | SELL | 2023-06-08 | $130K | — | Filing → |
| VIR | SELL | 2023-02-28 | $238K | — | Filing → |
| VIR | SELL | 2023-02-24 | $149K | — | Filing → |